Abstract
The severe dystroglycanopathy known as a form of limb-girdle muscular dystrophy
(LGMD2P) is an autosomal recessive disease caused by the point mutation T192M in α-
dystroglycan. Functional expression analysis in vitro and in vivo indicated that the mutation
was responsible for a decrease in posttranslational glycosylation of dystroglycan, eventually
interfering with its extracellular-matrix receptor function and laminin binding in skeletal
muscle and brain.
The X-ray crystal structure of the missense variant T190M of the murine N-terminal domain of
α-dystroglycan (50-313) has been determined, and showed an overall topology (Ig-like domain
followed by a basket-shaped domain reminiscent of the small subunit ribosomal protein S6)
very similar to that of the wild-type structure. The crystallographic analysis revealed a change
of the conformation assumed by the highly flexible loop encompassing residues 159-180.
Moreover, a solvent shell reorganization around Met190 affects the interaction between the
B1-B5 anti-parallel strands forming part of the floor of the basket-shaped domain, with likely
repercussions on the folding stability of the protein domain(s) and on the overall molecular
flexibility. Chemical denaturation and limited proteolysis experiments point to a decreased
stability of the T190M variant with respect to its wild-type counterpart. This mutation may
render the entire L-shaped protein architecture less flexible. The overall reduced flexibility and
stability may affect the functional properties of α-dystroglycan via negatively influencing its
binding behavior to factors needed for dystroglycan maturation, and may lay the molecular
basis of the T190M-driven primary dystroglycanopathy.
Original language | English |
---|---|
Pages (from-to) | N/A-N/A |
Journal | PLoS One |
Volume | 10 |
DOIs | |
Publication status | Published - 2015 |
Keywords
- dystroglycan